Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,835.00p on 29-01-2026 at 12:55:50
Change 17.50p 0.96%
Buy 1,835.50p
Sell 1,835.00p
Last Trade: Sell 150.00 at 1,835.00p
Day's Volume: 3,283,834
Last Close: 1,817.50p
Open: 1,812.00p
ISIN: GB00BN7SWP63
Day's Range 1,811.00p - 1,836.00p
52wk Range: 1,242.50p - 1,909.50p
Market Capitalisation: £74.03b
VWAP: 1,815.05899p
Shares in Issue: 4.03b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 150 1,835.00p Automatic Execution
12:55:50 - 29-Jan-26
Sell* 180 1,835.00p Automatic Execution
12:55:50 - 29-Jan-26
Sell* 1,500 1,835.00p Automatic Execution
12:55:50 - 29-Jan-26
Sell* 319 1,835.00p Automatic Execution
12:55:50 - 29-Jan-26
Sell* 725 1,835.00p Automatic Execution
12:55:50 - 29-Jan-26
Sell* 319 1,835.50p Automatic Execution
12:55:50 - 29-Jan-26
Sell* 319 1,835.50p Automatic Execution
12:55:50 - 29-Jan-26
Sell* 319 1,836.00p Automatic Execution
12:55:50 - 29-Jan-26
Sell* 728 1,836.00p Automatic Execution
12:55:50 - 29-Jan-26
Sell* 190 1,836.00p Automatic Execution
12:55:50 - 29-Jan-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
29th Jan 2026 (Thu) 1,812.00 1,836.00 1,811.00 1,817.50 3,283,834
28th Jan 2026 (Wed) 1,842.50 1,851.50 1,810.00 1,817.50 12,027,944
27th Jan 2026 (Tue) 1,834.00 1,865.50 1,832.50 1,862.50 4,702,280
26th Jan 2026 (Mon) 1,802.50 1,833.00 1,795.00 1,828.50 3,634,721
23rd Jan 2026 (Fri) 1,814.00 1,814.00 1,796.00 1,801.00 9,062,710
22nd Jan 2026 (Thu) 1,792.50 1,808.00 1,776.50 1,804.50 4,820,384
21st Jan 2026 (Wed) 1,786.50 1,798.50 1,777.00 1,787.50 6,414,843
20th Jan 2026 (Tue) 1,802.00 1,805.50 1,774.00 1,795.50 7,498,672
19th Jan 2026 (Mon) 1,800.00 1,816.00 1,793.00 1,816.00 5,056,429
16th Jan 2026 (Fri) 1,838.00 1,845.00 1,795.50 1,816.50 14,632,764
15th Jan 2026 (Thu) 1,890.50 1,895.50 1,845.00 1,848.00 4,980,454
14th Jan 2026 (Wed) 1,856.50 1,880.50 1,853.50 1,880.50 6,552,424
13th Jan 2026 (Tue) 1,868.50 1,874.00 1,833.00 1,858.00 5,789,190
12th Jan 2026 (Mon) 1,879.50 1,902.00 1,866.00 1,877.00 5,647,857
9th Jan 2026 (Fri) 1,875.00 1,896.00 1,871.00 1,886.00 6,348,596
8th Jan 2026 (Thu) 1,891.50 1,908.50 1,880.00 1,891.00 6,026,419
7th Jan 2026 (Wed) 1,902.00 1,909.50 1,869.50 1,901.50 7,532,634
6th Jan 2026 (Tue) 1,818.00 1,905.50 1,817.50 1,899.50 11,458,875
5th Jan 2026 (Mon) 1,846.00 1,847.00 1,800.00 1,820.50 5,344,789
2nd Jan 2026 (Fri) 1,828.00 1,849.00 1,821.00 1,831.50 5,188,093
1st Jan 2026 (Thu) 1,824.50 1,824.50 1,824.50 1,824.50 0
31st Dec 2025 (Wed) 1,833.50 1,835.00 1,824.50 1,824.50 2,468,218
30th Dec 2025 (Tue) 1,815.00 1,835.00 1,812.50 1,830.50 3,231,417
29th Dec 2025 (Mon) 1,815.50 1,823.50 1,810.50 1,823.00 3,647,051
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
26th Jan 2026 7:00 am RNS European Commission approves Arexvy for adults 18+
20th Jan 2026 7:05 am RNS GSK to acquire RAPT Therapeutics
20th Jan 2026 7:00 am RNS Agreement on changes to ViiV minority shareholding
16th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
15th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
13th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
7th Jan 2026 7:05 am RNS EC approval of Shingrix PFS
7th Jan 2026 7:00 am RNS Positive phase 3 data for GSK's bepirovirsen
6th Jan 2026 7:00 am RNS Exdensur approved in Japan
5th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

AstraZeneca plots bumper China investment in "exciting next chapter"

29th Jan 2026 10:29

(Alliance News) - Pharmaceutical firm AstraZeneca PLC on Thursday unveiled plans to invest USD15 billion in China through to 2030, in an announcement that coincides with UK Prime Minister Keir Starmer's visit to Beijing. Read More

UK earnings, trading statements calendar - next 7 days

28th Jan 2026 13:01

Read More

LONDON BROKER RATINGS: BofA raises St James's Place and Quilter

27th Jan 2026 09:44

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BRIEFING: Sage quarterly revenue up; Dr Martens sales decline

27th Jan 2026 07:59

(Alliance News) - The UK pub sector awaits a GBP100 million support package from the Treasury aimed at easing cost pressures, the Financial Times reports, while Sage posts 10% quarterly revenue growth and Dr Martens reports a dip in third-quarter revenue. Read More

GSK's RSV treatment, Arexvy, secures approval for wider use in EU

26th Jan 2026 08:27

(Alliance News) - GSK PLC on Monday said the European Commission has approved an expanded indication for its respiratory syncytial virus vaccine Arexvy, allowing use in all adults aged 18 and over. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,230.90
Change76.47

Login to your account

Forgot Password?

Not Registered